RT Journal Article
SR Electronic
T1 Lightweight Model For The Prediction of COVID-19 Through The Detection And Segmentation of Lesions in Chest CT Scans
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.30.20223586
DO 10.1101/2020.10.30.20223586
A1 Aram Ter-Sarkisov
YR 2020
UL http://medrxiv.org/content/early/2020/12/10/2020.10.30.20223586.abstract
AB We introduce a lightweight Mask R-CNN model that segments areas with the Ground Glass Opacity and Consolidation in chest CT scans. The model uses truncated ResNet18 and ResNet34 nets with a single layer of Feature Pyramid Network as a backbone net, thus substantially reducing the number of the parameters and the training time compared to similar solutions using deeper networks. Without any data balancing and manipulations, and using only a small fraction of the training data, COVID-CT-Mask-Net classification model with 6.12M total and 600K trainable parameters derived from Mask R-CNN, achieves 91.35% COVID-19 sensitivity, 91.63% Common Pneumonia sensitivity, 96.98% true negative rate and 93.95% overall accuracy on COVIDx-CT dataset (21191 images). We also present a thorough analysis of the regional features critical to the correct classification of the image. The full source code, models and pretrained weights are available on https://github.com/AlexTS1980/COVID-CT-Mask-Net.Competing Interest StatementThe authors have declared no competing interest.Funding StatementN/AAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data is open-source and referenced accordingly in the paper. https://github.com/AlexTS1980/COVID-CT-Mask-Net